Product logins

Find logins to all Clarivate products below.


Cybercitizen Health U.S. 2015 – Bottom Line Report – Mobile Strategy Playbook

For pharmas, mobile poses a critical opportunity for patient engagement. Smartphones have become the screen with which many consumers interact most throughout the day, serving as pocket information reference tools and organizational Swiss Army Knives, a source of health information lookup and health management resources. This report explores how consumers use their smartphones for health and how pharma might best inform and assist them through that device.

Questions answered in this report:

  • How does mobile technology fit into consumer health behavior?
  • How can mobile solutions drive greater patient engagement?
  • How can pharmas better target the mobile consumer?

Related Multichannel Engagement Reports

Report
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | Pneumococcal Vaccines
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | Pneumococcal Vaccines Our 2023 study among patients and caregivers provides detailed insights and recommendations on the…
Report
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | HPV Vaccines
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | HPV Vaccines Our 2023 study among patients and caregivers provides detailed insights and recommendations on the information-…
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | Colombia | Segmentation
Patient Multichannel Insights | 2022 | Cybercitizen Health | Colombia (Segmentation Data Tables)
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | Multiple Myeloma | Segmentation
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | Multiple Myeloma (Segmentation Data Deck)
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | AML VS CLL VS MM | Segmentation Data
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | AML VS CLL VS MM (Segmentation Data Comparison Table)